UK-453,061 Dose 1
A5271022
Phase 2 small_molecule terminated
Quick answer
UK-453,061 Dose 1 for HIV-1 is a Phase 2 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- HIV-1
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated